# US 2022/0054149 A1 · Vaccine generation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0054149 A1
- Document ID: US20220054149A1
- Status: Published application
- Kind: A1
- Application number: 17/244,610
- Filed: 2021-04-29
- Published: 2022-02-24
- Earliest claimed: 2020-08-21
- Assignees: University of Washington; Seattle Children's Hospital
- Applicants: University of Washington; Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Inventors: James Chen; Tanner Clark; Thomas Lendvay
- Web page: https://patentgrep.com/patent/US20220054149A1

## CPC

- A61B 17/20: for vaccinating or cleaning the skin previous to the vaccination {(Vaccination diagnosis other than by injuring the skin A61B10/0035)}
- A61K 41/10: Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K 9/0021: {Intradermal administration, e.g. through microneedle arrays or needleless injectors}
- A61K 39/00: Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N33/53)
- A61K 39/215: Coronaviridae, e.g. avian infectious bronchitis virus
- A61K 41/0057: {Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent}
- A61M 5/3145: {Filters incorporated in syringes}
- A61M 5/3293: {characterised by features of the needle hub}
- B01L 3/02: Burettes; Pipettes
- B01L 3/5029: {using swabs}
- C07K 14/11: Orthomyxoviridae, e.g. influenza virus
- C07K 14/165: Coronaviridae, e.g. avian infectious bronchitis virus
- A61B 10/0045: {Devices for taking samples of body liquids}
- A61K 2039/54: {characterised by the route of administration}
- A61M 2202/30: Vaccines
- A61M 2205/7509: for virus
- A61M 2209/04: Tools for specific apparatus
- B01L 2300/0681: Filter
- B01L 2300/0841: Drums
- B01L 2400/0478: pistons
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

An apparatus for vaccine generation includes a syringe with a cavity that includes a solution with photosensitizers. Microbial particles are added to the solution. A light source is capable of emitting one or more wavebands of light that are effectively absorbed by the one photosensitizers to generate singlet oxygen in the solution and other radical species that rapidly react with and damage lipids, proteins, DNA, and RNA of the microbial particles. This damage produces immunogens that can be applied as a vaccine to viruses and other infectious microbial particles. A plunger that fits within a proximal opening in the syringe is used for forcing the solution including the immunogens through the filter and out of the syringe while the photosensitizers, debris and unwanted microbial particles are trapped within the filter.

## Claims

### Claim 1

An apparatus for vaccine generation, comprising:
a syringe defining a cavity for containing a solution that includes one or more photosensitizers;
one or more light sources capable of emitting light at one or more wavebands that activate the one or more photosensitizers to generate singlet oxygen in the solution, wherein a plurality of immunogens are created in the solution by interaction of the singlet oxygen with a plurality of microbial particles that are added to the solution;
a plunger that fits within an opening at a proximal end of the syringe, wherein advancement of the plunger from the proximal end to another position at the distal end of the syringe causes evacuation of the solution with the plurality of immunogens through the other opening at the distal end; and
one or more filters capable of trapping one or more of debris and the plurality of microbial particles during evacuation of the solution.

### Claim 2 (depends on 1)

The apparatus of claim 1, wherein the one or more photosensitizers includes one or more of erythrosine, riboflavin, or methylene blue.

### Claim 3 (depends on 1)

The apparatus of claim 1, wherein the solution includes one or more aqueous solutions.

### Claim 4 (depends on 1)

The apparatus of claim 1, wherein the one or more filters include a pore size from 0.1 μm to 1.0 μm.

### Claim 5 (depends on 1)

The apparatus of claim 1, wherein the one or more filters, further comprise enabling removal of the one or more photosensitizers from the evacuated solution.

### Claim 6 (depends on 1)

The apparatus of claim 1, further comprising a microneedle patch to which the photodynamically treated solution is applied.

### Claim 7 (depends on 1)

The apparatus of claim 1, wherein the one or more filters, are positioned at one or more of the opening at the proximal end, the other opening at the distal end, one or more internal portions of the cavity, or an external outlet for the other opening at the distal end of syringe.

### Claim 8 (depends on 7)

The apparatus of claim 7, further comprising a needle that is capable of attaching to an external outlet for the other opening at the distal end of the syringe, wherein the needle is capable of delivering the evacuated solution for one or more of an intradermal, intramuscular, or intravenous injection into a user.

### Claim 9 (depends on 1)

The apparatus of claim 1, wherein the cavity of the syringe further comprises a transparent material or a translucent material that is made from plastic, glass or polymer.

### Claim 10 (depends on 1)

The apparatus of claim 1, wherein the one or more light sources are disposed inside the cavity of the syringe, external to the cavity of the syringe, or incorporated into a wall of the cavity of the syringe.

### Claim 11

A method for vaccine generation, comprising:
providing a solution that includes one or more photosensitizers into a syringe that defines a cavity for containing the solution;
adding a plurality of microbial particles to the solution;
employing one or more light sources to emit light at one or more wavebands that activate the one or more photosensitizers to generate singlet oxygen in the solution, wherein one or more types of immunogens are created by the singlet oxygen interacting with the plurality of microbial particles in the solution;
advancing a plunger that fits within an opening at a proximal end of the syringe towards a distal end of the syringe to cause evacuation of the solution with the plurality of immunogens through another opening at the distal end; and
employing one or more filters to trap one or more of debris or the plurality of microbial particles during evacuation of the solution.

### Claim 12

A method for generating a vaccine, comprising:
filling a syringe that defines a cavity with a solution including one or more photosensitizers;
adding a plurality of microbial particles to the solution in the syringe;
exposing the solution to light while inside the cavity of the syringe, wherein the light is effectively absorbed by the one or more photosensitizers to generate singlet oxygen in the solution, wherein the singlet oxygen inactivates the plurality of microbial particles and produce a plurality of immunogens in the solution; and
pressing a plunger within the cavity of the syringe to force the solution through one or more filters to produce a fluid containing the plurality of immunogens for use as a vaccine.

### Claim 13 (depends on 12)

The method of claim 12, wherein the plurality of microbial particles include one or more a virus, viroid, bacteria, archaea, protist, protozoa, prion, fungus, or toxin.

### Claim 14 (depends on 12)

The method of claim 12, wherein the light exposes the solution to one or more of sunlight, ambient light, or artificial light at one or more wavebands or wavelengths of light that are effectively absorbed by the one or more photosensitizers to generate the singlet oxygen.

### Claim 15 (depends on 12)

The method of claim 12, wherein the one or more photosensitizers further comprise methylene blue derivatives, methylene blue, chlorophyll derivatives, tetrapyrrole structures, porphyrins, chlorins, bacteriochlorins, phthalocyanines, texaphyrins, prodrugs, aminolevulinic acids, phenothiaziniums, squaraine, boron compounds, transition metal complexes, hypericin, riboflavin, curcumin, psoralens, tetracyclines, flavins, riboflavin, or titanium dioxide.

### Claim 16 (depends on 12)

The method of claim 12, further comprising applying the fluid containing the plurality of immunogens to a microneedle patch.

### Claim 17 (depends on 12)

The method of claim 12, wherein the syringe further comprises locating the one or more filters proximal to an end of the syringe, wherein a needle is attached to a syringe tip for intradermal, intramuscular, or intravenous injection of the fluid into a patient.

### Claim 18 (depends on 12)

The method of claim 12, further comprising filtering the one or more photosensitizers from the fluid.

### Claim 19 (depends on 12)

The method of claim 12, further comprising filtering one or more of debris or the plurality of microbial particles from the fluid.

### Claim 20 (depends on 12)

The method of claim 12, further comprising collecting a sample of the plurality of microbial particles from a patient and transferring the sample to the cavity of the syringe.
